drugset / Trial / NCT00542984

Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis

NCT00542984

Phase 3 Completed 70 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare in postmenopausal women with established osteoporosis the effect of treatment with teriparatide 20 micrograms/day subcutaneous with the effect of salmon calcitonin 100 IU/day subcutaneous on change in lumbar spine BMD.

Timeline

Start
2003-08
Primary completion
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Teriparatide Protein / enzyme biologic 20 ug Subcutaneous
Comparator salmon calcitonin Unknown 100 iu Subcutaneous